Publicacións (23) Publicacións de Ana López Real

2024

  1. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

  2. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study

    Multiple Sclerosis and Related Disorders, Vol. 90

  3. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence , Vol. 18, pp. 1163-1171

  4. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 91

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  3. Multiple sclerosis and fatigue. It is necessary to improve

    Rehabilitacion

2016

  1. Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia

    Revista de Neurologia, Vol. 63, pp. S13-S18

2014

  1. Long-term effectiveness of glatiramer acetate in clinical practice conditions

    Journal of Clinical Neuroscience, Vol. 21, Núm. 12, pp. 2212-2218

2012

  1. Anatomical, pathophysiological and neurochemical bases of rigid-akinetic syndrome

    Revista de Neurologia, Vol. 54, pp. S1-S12

2010

  1. Alteraciones de la esfera emocional y el control de los impulsos en la enfermedad de Parkinson

    Revista de Neurologia, Vol. 50, Núm. SUPPL. 2

  2. Trombosis venosa cerebral en adultos en el Complejo Hospitalario-Universitario de A Coruña España. Revisión clínico-radiológica de 48 casos diagnosticados entre 1995 Y 2005

    Revista Médicas UIS, Vol. 23, Núm. 1

2008

  1. Endovascular treatment of carotid disease in patients at high surgical risk

    Revista de Neurologia, Vol. 46, Núm. 7, pp. 391-396

  2. Guillain-Barŕ syndrome complicating a urinary tract infection due to Escherichia coli

    Revista de Neurologia

  3. Ischaemic stroke and sexual headache

    Revista de Neurologia

  4. Staghorn calculi secondary to topiramate

    Farmacia Hospitalaria

2007

  1. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

    Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

2005

  1. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism

    Journal of Neuroscience Research, Vol. 81, Núm. 6, pp. 865-873

2003

  1. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats

    Experimental Brain Research, Vol. 153, Núm. 1, pp. 92-99

  2. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models

    Brain Research, Vol. 969, Núm. 1-2, pp. 135-146